Corcept Therapeutics CORT Q1 2026 Earnings Severe Earnings Miss Overshadows Operational Developments CCAP Q1 2026 Earnings Narrow EPS Miss Amid Steady Portfolio Performance JXN Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds RCAT Q1 2026 Earnings Negative EPS Surprise as Strategic Initiatives Continue CRVS Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Clinical Development FOXF Q1 2026 Earnings EPS Beats Estimates by 1153 Amid Cost Discipline Energizer Holdings Q1 2026 Earnings EPS Crushes Estimates by Over 100 as Cost Initiatives Drive Profitability RWAYL Q1 2026 Earnings EPS Misses Estimates but Share Price Edges Higher CUE Q3 2025 Earnings Narrower Loss Drives Positive Market Response REYN Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher BVN Q4 2025 Earnings Stunning EPS Beat Driven by Operational Strength and Higher Metal Prices MTVA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline THFF Q1 2026 Earnings Modest EPS Beat Fails to Lift Shares